Not registered yet? Get a free account.
Sign UpYou're about to leave our website and go to an external link. Are you sure?
The company engages in the business of custom manufacturing of agrochemical active ingredients, intermediates and fine chemicals.
Deccan Fine Chemicals (India) Private Limited, is an unlisted private company incorporated on 24 August, 2006. It is classified as a private limited company and is located in Hyderabad, Telangana. It's authorized share capital is INR 65.00 cr and the total paid-up capital is INR 46.87 cr.
Read more
This action will use 1 of your credits. Are you sure you want to go ahead?
** All rupee values in INR crores. Based on March 2024 numbers.
* GST not included
** Reports & MCA filings will be based on the latest available financials.
State | Type | Address |
---|
Read more
Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | |
---|---|---|---|---|---|
Sales | 3,585.4 | 4,192.2 | 6,031.7 | 8,382.7 | 8,101.5 |
Operating profit | 923.5 | 1,190.1 | 1,565.2 | 2,247.4 | 2,131.5 |
Net profit | 503.1 | 668.4 | 880.4 | 1,124.0 | 974.0 |
Gross margin | 41.4 | 43.3 | 41.1 | 40.8 | 41.0 |
Operating margin | 25.8 | 28.4 | 25.9 | 26.8 | 26.3 |
Net margin | 13.7 | 15.8 | 14.3 | 13.1 | 11.8 |
Networth | 1,533.0 | 2,113.4 | 2,906.8 | 3,865.4 | 4,675.9 |
Borrowings | 2,067.9 | 2,236.5 | 3,428.5 | 4,492.7 | 5,419.1 |
Assets | 4,533.3 | 5,727.7 | 7,741.4 | 9,959.0 | 11,817.8 |
Debt to equity | 1.4 | 1.1 | 1.2 | 1.2 | 1.2 |
Current ratio | 1.5 | 1.2 | 0.9 | 1.1 | 1.0 |
ROE | 32.8 | 31.6 | 30.3 | 29.1 | 20.8 |
Days payable | 87.0 | 96.0 | 101.0 | 74.0 | 76.0 |
WC days | 64.0 | 28.0 | -13.0 | 10.0 | -6.0 |
Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | |
---|---|---|---|---|---|
Equity Capital | 46.9 | 46.9 | 46.9 | 46.9 | 46.9 |
Reserves | 1,486.1 | 2,066.5 | 2,859.9 | 3,818.5 | 4,629.0 |
Borrowings + | 2,067.9 | 2,236.5 | 3,428.5 | 4,492.7 | 5,419.1 |
Long term borrowings | 1,499.0 | 1,691.1 | 1,225.2 | 2,240.5 | 2,921.2 |
Short term borrowings | 568.9 | 545.4 | 2,203.3 | 2,252.2 | 2,497.9 |
Trade payables + | 503.2 | 623.1 | 980.4 | 1,012.1 | 1,001.7 |
Days payable | 87.0 | 96.0 | 101.0 | 74.0 | 76.0 |
Other liabilities + | 932.4 | 1,377.7 | 1,406.1 | 1,600.9 | 1,722.8 |
Other non-current liabilities | 214.6 | 128.6 | 189.2 | 239.7 | 318.6 |
Other current liabilities | 214.6 | 626.0 | 236.5 | 349.1 | 402.4 |
Total liabilities | 4,533.3 | 5,727.7 | 7,741.4 | 9,959.0 | 11,817.8 |
Fixed Assets + | 2,412.6 | 3,383.4 | 4,228.5 | 5,562.2 | 7,438.9 |
Tangible assets | 1,757.7 | 2,998.8 | 3,799.6 | 4,742.0 | 6,356.9 |
CWIP | 654.9 | 384.6 | 428.9 | 820.2 | 1,081.9 |
Intangible assets | - | - | - | - | - |
LT loans and advances | - | 14.0 | 8.8 | 7.2 | - |
Other non-current assets | 202.9 | 216.0 | 299.0 | 549.4 | 600.9 |
Current assets + | 1,917.8 | 2,114.2 | 3,205.2 | 3,840.1 | 3,778.1 |
Inventories | 623.7 | 928.3 | 1,559.3 | 2,184.3 | 1,985.3 |
Trade receivables | 749.6 | 673.5 | 1,006.0 | 922.3 | 1,245.0 |
Cash and cash equivalents | 407.1 | 367.6 | 498.4 | 463.1 | 269.6 |
ST loans and advances | 138.1 | - | - | 1.6 | - |
Other current assets | -0.7 | 144.8 | 141.5 | 268.8 | 278.2 |
Total assets | 4,533.3 | 5,727.7 | 7,741.4 | 9,959.0 | 11,817.8 |
Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | |
---|---|---|---|---|---|
Sales + | 3,585.4 | 4,192.2 | 6,031.7 | 8,382.7 | 8,101.5 |
Sales growth % | 31.81 | 16.92 | 43.88 | 38.98 | -3.35 |
Expenses + | 3,049.7 | 3,314.8 | 4,965.0 | 7,062.0 | 6,935.5 |
Cost of goods | 2,099.7 | 2,376.1 | 3,553.2 | 4,965.1 | 4,782.9 |
Employee cost | 159.2 | 159.2 | 188.5 | 233.9 | 278.5 |
Other costs | 403.1 | 466.8 | 724.8 | 936.3 | 908.5 |
Operating profit + | 923.5 | 1,190.1 | 1,565.2 | 2,247.4 | 2,131.5 |
Operating margin % | 25.8 | 28.4 | 25.9 | 26.8 | 26.3 |
Other income | 81.0 | 45.5 | 114.6 | 192.5 | 146.0 |
Interest | 183.2 | 118.6 | 214.0 | 542.7 | 455.7 |
Depreciation | 204.6 | 194.1 | 284.5 | 384.0 | 509.9 |
Exceptional items | - | - | - | - | - |
Profit before tax | 616.7 | 922.9 | 1,181.3 | 1,513.2 | 1,311.9 |
Tax | 113.6 | 254.5 | 301.0 | 389.2 | 337.9 |
Profit - disc. ops | - | - | - | - | - |
Net profit | 503.1 | 668.4 | 880.4 | 1,124.0 | 974.0 |
Net margin % | 13.7 | 15.8 | 14.3 | 13.1 | 11.8 |
Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | |
---|---|---|---|---|---|
Solvency + | |||||
Total Debt/Equity | 1.4 | 1.1 | 1.2 | 1.2 | 1.2 |
Net Debt/Equity | 1.1 | 0.9 | 1.0 | 1.0 | 1.1 |
Total Debt/Assets | 0.5 | 0.4 | 0.4 | 0.5 | 0.5 |
Total Assets/Equity | 3.0 | 2.7 | 2.7 | 2.6 | 2.5 |
Liquidity + | |||||
Current Ratio | 1.5 | 1.2 | 0.9 | 1.1 | 1.0 |
Quick Ratio | 1.0 | 0.7 | 0.5 | 0.5 | 0.5 |
Interest Coverage | 5.0 | 10.0 | 7.3 | 4.1 | 4.7 |
Performance | |||||
Gross Margin | 41.4 | 43.3 | 41.1 | 40.8 | 41.0 |
Operating Margin | 25.8 | 28.4 | 25.9 | 26.8 | 26.3 |
Net Margin | 13.7 | 15.8 | 14.3 | 13.1 | 11.8 |
Return + | |||||
Return on Equity | 32.8 | 31.6 | 30.3 | 29.1 | 20.8 |
Pre-tax ROCE | 23.6 | 26.9 | 31.9 | 32.2 | 22.2 |
Return on Assets | 11.1 | 11.7 | 11.4 | 11.3 | 8.2 |
Pre-tax ROIC | 22.5 | 25.0 | 21.9 | 23.6 | 16.5 |
Efficiency + | |||||
Days Payable | 87.0 | 96.0 | 101.0 | 74.0 | 76.0 |
Days Inventory | 108.0 | 143.0 | 160.0 | 161.0 | 152.0 |
Days Receivable | 76.0 | 59.0 | 61.0 | 40.0 | 56.0 |
Fixed Asset Turnover | 1.5 | 1.2 | 1.4 | 1.5 | 1.1 |
Total Asset Turnover | 0.8 | 0.7 | 0.8 | 0.8 | 0.7 |
Working Capital | |||||
Cash Conversion Cycle | 97.0 | 106.0 | 120.0 | 127.0 | 132.0 |
Working Capital Days | 64.0 | 28.0 | -13.0 | 10.0 | -6.0 |
SBICap Trustee Company Limited
No. of Loans: 3
Total Amount : 13,850.5 cr
Designation | Name | DIN/PAN | Tenure |
---|---|---|---|
Managing Director | Satyanarayana Gokaraju | 00524152 | 17 years |
Kmp | Purushothaman Varadarajan | <HIDDEN> | 2 years |
Director | Datla Venkata Satyanarayana Raju | 01641921 | 1 years |
Whole-time Director | Venkata Lakshmipathi Raju Kanumuri
Shareholder
|
02000929 | 17 years |
Director | Vivek Vasant Save
Shareholder
|
05191822 | 7 years |
CFO | Hemanath Thakar
Shareholder
|
<HIDDEN> | 6 years |
Director | Takahiro Tokuda | 09544810 | 3 years |
Name | Status | Paid up Capital | Common Directors | Address |
---|---|---|---|---|
SURREAL TECHNOLOGIES INDIA PRIVATE LIMITED |
Active
|
1.3 L | 1 | Telangana |
LONZA INFRASTRUCTURE PRIVATE LIMITED |
Strike Off
|
1.0 L | 1 | Maharashtra |
ESCIENTIA BIOPHARMA PRIVATE LIMITED |
Active
|
1.1 Cr | 1 | Telangana |
ESCIENTIA ADVANCED SCIENCES PRIVATE LIMITED |
Active
|
21.5 Cr | 1 | Telangana |
IFFCO-MC CROP SCIENCE PRIVATE LIMITED |
Active
|
41.2 Cr | 1 | Delhi |
GODAVARI FERTILISERS AND CHEMICALS LTD |
Amalgamated
|
32.0 Cr | 1 | Telangana |
Name | State / Country | Incorporation Year | Paidup Capital |
---|---|---|---|
DECCAN ADVANCED SCIENCES PRIVATE LIMITED | Telangana | 2020 | ₹ 330.0 Cr |
ESCIENTIA ADVANCED SCIENCES PRIVATE LIMITED | Telangana | 2013 | ₹ 21.5 Cr |
ESCIENTIA BIOPHARMA PRIVATE LIMITED | Telangana | 2008 | ₹ 1.1 Cr |
Deccan Fine Chemicals USA LLC, USA | United States | - | - |
Primopus A.G., Switzerland | Switzerland | - | - |
Escientia Life Sciences LLC, USA | United States | - | - |
The incorporation date of DECCAN FINE CHEMICALS (INDIA) PRIVATE LIMITED is 24 August, 2006
The authorized share capital of DECCAN FINE CHEMICALS (INDIA) PRIVATE LIMITED is INR ₹ 65.0 Cr.
The paid-up capital of DECCAN FINE CHEMICALS (INDIA) PRIVATE LIMITED is INR ₹ 46.9 Cr.
The registered address of DECCAN FINE CHEMICALS (INDIA) PRIVATE LIMITED is 8-2-293/82/A/74A, ROAD NO.9 JUBILEE HILLS HYDERABAD Telangana - 500033
The CIN number of DECCAN FINE CHEMICALS (INDIA) PRIVATE LIMITED is U24117TG2006PTC050967.